Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways
Malignant ascites is commonly produced in advanced epithelial ovarian cancer (EOC) and serves as unique microenvironment for tumour cells. Acellular ascites fluid (AAF) is rich in signalling molecules and has been proposed to play a role in the induction of chemoresistance. Through in vitro testing...
Saved in:
Main Authors: | Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, Johannes Landskron, Lise‐Lotte Flage‐Larsen, Alexandra Gade, Line Bjørge, Alfonso Urbanucci, Kjetil Taskén |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13726 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01) -
Non-Cirrhotic Ascites: Causes and Management
by: Paul Carrier, et al.
Published: (2024-10-01) -
A Rare Case of Deep Pelvic Endometriosis Presenting with Serous Ascites and Infertility
by: Türkan Gürsu, et al.
Published: (2015-08-01) -
Ascites of unknown origin in infant: a rare case report
by: Rendi Aji Prihaningtyas, et al.
Published: (2024-09-01) -
Case report and literature review of refractory hypoalbuminemic ascites caused by so-dium valproate
by: Hui-Min YANG, et al.
Published: (2021-10-01)